Vaccine and Treatment Evaluation Units: Phase IV Clinical Trial in Adults with Community Acquired Pneumonia to Assess the Effect of Early Empiric Antifungal Treatment of Coccidioidomycosis Pneumonia

疫苗和治疗评估单位：针对成人社区获得性肺炎的 IV 期临床试验，评估早期经验性抗真菌治疗球孢子菌肺炎的效果

• 批准号: 10204827
• 负责人: SUSANNA NAGGIE
• 金额: $ 66.86万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-06-10 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10204827
• 关键词: Adult; Antifungal Agents; Antimicrobial Resistance; Coccidioides immitis; Coccidioides posadasii; Coccidioidomycosis; Communities; Conduct Clinical Trials; Contracts; Evaluation; Individual; Investigation; Phase IV Clinical Trials; Pneumonia; Population; Resources; Route; System; Vaccines; design; infectious disease treatment; named group; novel

The Vaccine and Treatment Evaluation Units (VTEUs) are a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising vaccines and treatments for infectious disease. Investigations of novel product delivery systems and routes of delivery may also be conducted. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

疫苗和治疗评估单位（VTEU）是学术中心和组织内的个人合同联盟，为临床试验的设计和实施提供现成的资源，以评估有前途的疫苗和传染病治疗方法。还可以对新的产品输送系统和输送途径进行研究。一般而言，产品将在正常健康人群中进行评价;然而，也可用于特殊人群。